Trial Profile
Study of belimumab and rituximab on health-related quality of life in patients with systemic lupus erythematosus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Belimumab (Primary) ; Rituximab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 18 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism